Cordyceps sinensis enhances the efficacy of anti-PD-1 immunotherapy in Lewis lung adenocarcinoma

Abstract Lung cancer, primarily non-small cell lung cancer (NSCLC), causes the highest cancer-related mortality. Although PD-1/PD-L1 inhibitors have improved survival in advanced NSCLC, they can cause immune-related adverse events. Cordyceps sinensis (C. sinensis), a traditional Chinese medicine use...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yingying Liu, Yaqi Gao, Suonanlamao, Yuanan Ma, Yuancan Xiao, Lixin Wei, Wenbin Zhou
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2026-02-01
Sarja:	Scientific Reports
Aiheet:	Cordyceps sinensis Anti-mouse PD-1 Lewis lung adenocarcinoma Transcriptomics Metabolomics Anti-tumor effect
Linkit:	https://doi.org/10.1038/s41598-026-37878-0
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!